Format

Send to

Choose Destination
High Blood Press Cardiovasc Prev. 2013 Jun;20(2):89-92. doi: 10.1007/s40292-013-0014-3. Epub 2013 May 8.

The use of the RESPeRATE device to lower blood pressure in inner city obese adolescents and children: a pilot feasibility study.

Author information

1
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of California, San Francisco, CA 94134, USA. wojcickij@peds.ucsf.edu

Abstract

The RESPeRATE device was tested for feasibility of use in a population of overweight and obese children and adolescents (n = 10) in San Francisco, CA. After a 2-week and then a 2-month period, participants were interviewed on their frequency of use and attitudes towards the device. A high percentage stated that they enjoyed using the device at 2 months (90%) and 80% stated that they would recommend use to a friend or relative. Future studies are needed to assess the efficacy of the RESPeRATE device in lowering blood pressure and helping with weight loss/weight management in obese and overweight children.

PMID:
23653175
PMCID:
PMC4456090
DOI:
10.1007/s40292-013-0014-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center